- Home
- HSCS vs SPRC Comparison
HSCS vs SPRC Comparison
Compare HSCS & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- SPRC
- Stock Information
- Founded
- HSCS 2007
- SPRC 2004
- Country
- HSCS United States
- SPRC Israel
- Employees
- HSCS N/A
- SPRC N/A
- Industry
- HSCS Medical Specialities
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- HSCS Health Care
- SPRC Health Care
- Exchange
- HSCS Nasdaq
- SPRC Nasdaq
- Market Cap
- HSCS 3.7M
- SPRC 3.4M
- IPO Year
- HSCS 2022
- SPRC N/A
- Fundamental
- Price
- HSCS $3.56
- SPRC $0.32
- Analyst Decision
- HSCS Strong Buy
- SPRC
- Analyst Count
- HSCS 2
- SPRC 0
- Target Price
- HSCS $13.00
- SPRC N/A
- AVG Volume (30 Days)
- HSCS 19.7K
- SPRC 6.0M
- Earning Date
- HSCS 07-28-2025
- SPRC 02-15-2025
- Dividend Yield
- HSCS N/A
- SPRC N/A
- EPS Growth
- HSCS N/A
- SPRC N/A
- EPS
- HSCS N/A
- SPRC N/A
- Revenue
- HSCS N/A
- SPRC $1,306,000.00
- Revenue This Year
- HSCS N/A
- SPRC N/A
- Revenue Next Year
- HSCS N/A
- SPRC N/A
- P/E Ratio
- HSCS N/A
- SPRC N/A
- Revenue Growth
- HSCS 261.17
- SPRC N/A
- 52 Week Low
- HSCS $2.36
- SPRC $0.20
- 52 Week High
- HSCS $7.57
- SPRC $1.79
- Technical
- Relative Strength Index (RSI)
- HSCS 48.30
- SPRC 49.39
- Support Level
- HSCS $3.71
- SPRC $0.30
- Resistance Level
- HSCS $4.54
- SPRC $0.32
- Average True Range (ATR)
- HSCS 0.38
- SPRC 0.02
- MACD
- HSCS -0.04
- SPRC -0.00
- Stochastic Oscillator
- HSCS 22.27
- SPRC 43.88
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.